Biochemically balanced peritoneal dialysis solutions

Details Biochemically balanced peritoneal dialysis solutions Biochemically balanced peritoneal dialysis solutions

2006-03-14

2006-03-14

Keys, Rosalynd (Department: 1621)

Drug, bio-affecting and body treating compositions

Inorganic active ingredient containing

Carbonate

C424S665000, C424S680000, C424S682000, C424S700000, C424S722000, C514S557000, C514S578000, C210S645000, C604S029000

Reexamination Certificate

active

07011855

ABSTRACT:
A peritoneal dialysis solution that is biochemically balanced to correct metabolic acidosis associated with chronic renal failure in a more physiological manner. The peritoneal dialysis solution has a physiological pH, e.g., pH of 7.0 to 7.4, and contains bicarbonate at a concentration that is found in normal blood. Additionally, the solution contains carbon dioxide at a partial pressure that is similar to partial pressure of carbon dioxide found in normal blood. The peritoneal dialysis solution also contains a weak acid with a pKa of less than 5.0.

REFERENCES:
patent: 4396383 (1983-08-01), Hart
patent: 4465488 (1984-08-01), Richmond et al.
patent: 4489535 (1984-12-01), Veltman
patent: 4584176 (1986-04-01), Oliver et al.
patent: 4630727 (1986-12-01), Feriani et al.
patent: 4663166 (1987-05-01), Veech
patent: 4756838 (1988-07-01), Veltman
patent: 4863714 (1989-09-01), Sovak et al.
patent: 4879280 (1989-11-01), Seyffart et al.
patent: 4959175 (1990-09-01), Yatzidis
patent: 5039609 (1991-08-01), Klein
patent: 5100677 (1992-03-01), Veech
patent: 5141492 (1992-08-01), Dadson et al.
patent: 5211643 (1993-05-01), Reinhardt et al.
patent: 5296242 (1994-03-01), Zander
patent: 5383324 (1995-01-01), Segers et al.
patent: 5423421 (1995-06-01), Inoue et al.
patent: 5431496 (1995-07-01), Balteau et al.
patent: 5462526 (1995-10-01), Barney et al.
patent: 5509898 (1996-04-01), Isono et al.
patent: 5536469 (1996-07-01), Jonsson et al.
patent: 5560403 (1996-10-01), Balteau et al.
patent: 5610170 (1997-03-01), Inoue et al.
patent: 5706937 (1998-01-01), Futagawa et al.
patent: 5853388 (1998-12-01), Semel
patent: 5871477 (1999-02-01), Isono et al.
patent: 5945129 (1999-08-01), Knerr et al.
patent: 6020007 (2000-02-01), Veech
patent: 19748290 (1999-05-01), None
patent: 0 083 360 (1981-10-01), None
patent: 0 165 933 (1986-02-01), None
patent: 0 249 667 (1987-12-01), None
patent: 0 278 100 (1988-06-01), None
patent: 0 277 868 (1988-10-01), None
patent: 0 209 607 (1989-12-01), None
patent: 0 399 549 (1990-11-01), None
patent: 0 439 061 (1991-07-01), None
patent: 0613688 (1994-09-01), None
patent: 0 647 145 (1995-04-01), None
patent: 0 776 649 (1997-06-01), None
patent: 0935967 (1998-03-01), None
patent: 0 845 970 (2000-01-01), None
patent: 2753099 (1998-03-01), None
patent: 56164113 (1981-12-01), None
patent: 2304026 (1990-12-01), None
patent: 3195561 (1991-08-01), None
patent: 5105633 (1993-04-01), None
patent: 6105905 (1994-04-01), None
patent: 7252137 (1995-10-01), None
patent: 8131542 (1996-05-01), None
patent: 8164199 (1996-06-01), None
patent: 9087182 (1997-03-01), None
patent: 9110703 (1997-04-01), None
patent: 9301875 (1997-11-01), None
patent: 10201821 (1998-08-01), None
patent: 11-9659 (1999-01-01), None
patent: 11004872 (1999-01-01), None
patent: 11019178 (1999-01-01), None
patent: WO 86/03407 (1986-06-01), None
patent: WO 87/03809 (1987-07-01), None
patent: WO 91/18610 (1991-12-01), None
patent: WO 95/19778 (1995-07-01), None
patent: WO 96/01118 (1996-01-01), None
patent: WO 97/05851 (1997-02-01), None
patent: 98/10733 (1998-03-01), None
patent: 99/01144 (1999-01-01), None
patent: 99/09953 (1999-03-01), None
patent: 99/09953 (1999-04-01), None
patent: 99/22746 (1999-05-01), None
patent: 99/27885 (1999-06-01), None
Schambye et al.,The Cytotoxicity of Continuous Ambulatory Peritoneal Dialysis Solutions with Different Bicarbonate/Lactate Ratios, Peritoneal Dialysis International, vol. 13, Suppl. 2 ,Oct. 1-4, 1992, pp. S116-S118.
American Society for Artificial Internal Organs, 1994 Abstracts.
Boen ST,A Clinical Study of Factors Governing its Effectiveness, Peritoneal Dialysis, p. 76, Van Gorcum & Co., Assen, The Netherlands (1959).
Faller et al., “Loss of Ultrafiltration in Continuous Ambulatory Peritoneal Dialysis: A Role for Acetate”, Peritoneal Dialysis Bulletin, Jan.-Mar. 1984, pp. 10-13.
Feriani et al.,Bicarbonate Solutions for Peritoneal Dialysis: A Reality, Int J ARtif Organs 8:57-58 (1985).
Ing et al.,Preparation of Bicarbonate-Containing Dialysate for Peritoneal Dialysis, Int J Artif Organs, vol. 6, No. 4, pp. 217-218 (1983).
The Merck Index, 12thEd., Merck Research Laboratories, Whitehouse Station, NJ, p. 1472 (1996).
Murphey et al.,Use of an ARtificial Kidney, J. Lab. Clin. Med., vol. 40, pp. 436-444 (1952).
Odel HM et al., Peritoneal Lavage as an Effective Means of Extrarenal Excretion. A Clinical Appraisal, American Journal of Medicine, vol. 9, 63-88 (1950).
Schambye et al.,The Cytotoxicity of Continuous Ambulatory Peritoneal Dialisis Solutions with Different Bicarbonate/Lactate Ratios, Peritoneal Dialysis International, vol. 13, Suppl. 2, Oct. 1-4, 1992, pp. S116-S118.
Simonsen et al., Less Infusion Pain and Elevated Level of Cancer Antigen 125 by the Use of a New and More Biocompatible PD Fluid, Advances in Peritoneal Dialysis, vol. 12, pp. 156-160 (1996).
T.S. Ing. et al., Bicarbonate-Buffered Peritoneal Dialysis, The International Journal of Artificial Organs, vol. 8, no. 3, p. 121-124 (1985).

Affiliated with

Also associated with

Rating

Biochemically balanced peritoneal dialysis solutions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biochemically balanced peritoneal dialysis solutions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biochemically balanced peritoneal dialysis solutions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3594569